About ATANIS Biotech
ATANIS Biotech is a Healthcare company based in Sursee (Switzerland) founded in 2021 by Thomas Kaufmann, Alexander Eggel, Noemi Bachmeier Zbaren, and JeanPierre Kinet. Developer of a cell-based assay for the diagnosis of allergies. Its chief executive, as recorded, is JeanPierre Kinet. ATANIS Biotech offers products and services including FAST-PASE®. Its focus areas include Life Sciences, Life Sciences Platforms and Tools, Research Assays and Cell Based Assays. Its legal entity is ATANIS Biotech AG.
Company details
ATANIS Biotech was founded in 2021 in Sursee, Switzerland, within the biotechnology sector focused on allergy diagnostics. A cell-based assay is developed through FAST-PASE technology to replicate allergic reactions in vitro, thereby isolating patients from allergens during testing. Operations center on advancing diagnostic tools for safer allergy identification, with leadership provided by co-founders including JeanPierre Kinet as CEO and Noemi Bachmeier Zbaren as Managing Director.
- Headquarters Sursee, Switzerland
- Founders Thomas Kaufmann, Alexander Eggel, Noemi Bachmeier Zbaren, JeanPierre Kinet
- SectorsHealthcare
- Email••••••••
- Website atanis-biotech.com
- Social LinkedIn
- Legal Name Atanis Biotech Ag
- Investors
Products & Services of ATANIS Biotech
ATANIS Biotech offers a comprehensive portfolio of products and services, including FAST-PASE®.
A tool for fast and reliable functional allergy screening services.
Funding Insights of ATANIS Biotech
- Total Rounds 1
- Investors Count 1
All 1 funding rounds of ATANIS Biotech with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Oct 2024 | Seed | – | Spectrum Value Management | – |
1 investors in total: 1 institutional.
Investors in ATANIS Biotech
ATANIS Biotech has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Spectrum Value Management.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Provides wealth management and advisory services for family investments. | 2002 | s-vm.com |
Investor details for ATANIS Biotech
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of ATANIS Biotech
4 people are tracked at ATANIS Biotech (4 in leadership).
| Name | Role | Group |
|---|---|---|
Thomas Kaufmann | Co-Founder | Leadership |
Alexander Eggel | Co-Founder | Leadership |
Noemi Bachmeier Zbaren | Co-Founder & Managing Director | Leadership |
JeanPierre Kinet | Co-Founder & CEO | Leadership |
Complete people profiles for ATANIS Biotech
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of ATANIS Biotech
2 dated milestones of ATANIS Biotech across 3 years, from founding to its latest funding, stage changes and deals.
- Founded ATANIS Biotech is founded.
- Funding First funding round.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Atanis Biotech
Complete news archive for ATANIS Biotech
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about ATANIS Biotech
ATANIS Biotech was founded in 2021 and raised its 1st funding round 3 years after it was founded.
ATANIS Biotech is headquartered in Sursee, Switzerland. It is registered at Sursee, Luzern, Switzerland.
JeanPierre Kinet is the CEO of ATANIS Biotech, as recorded in our data. They have also founded this company.
ATANIS Biotech was founded in 2021 in Sursee, Switzerland, within the biotechnology sector focused on allergy diagnostics. A cell-based assay is developed through FAST-PASE technology to replicate allergic reactions in vitro, thereby isolating patients from allergens during testing. Operations center on advancing diagnostic tools for safer allergy identification, with leadership provided by co-founders including JeanPierre Kinet as CEO and Noemi Bachmeier Zbaren as Managing Director.
ATANIS Biotech offers FAST-PASE®.
ATANIS Biotech has 1 investor. Key investors include Spectrum Value Management.
ATANIS Biotech operates through Atanis Biotech Ag.